Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link
OpportunityPostedClosing

U.S. Nuclear Regulatory Commission Funding Opportunity Announcement (FOA), Scholarship and Fellowship Education Grant, Faculty Development Grant, and Trade School and Community College Scholarship Grant, Fiscal Year (FY) 2020

Agency: NRC

02/10/2004/10/20

Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

02/06/2006/29/20

Naval Service Warfare Center (NSWC) Crane Office-Wide

Agency: CRANE

02/03/2003/04/20

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

Reproducible Cells and Organoids via Directed- Differentiation Encoding

Agency: NSF

02/01/2004/30/20

National and State Tobacco Control Program

Agency: NCCDPHP

01/28/2004/03/20

Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIA

01/27/2006/17/20

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/27/2005/07/23

FY2020 Research Opportunities in Accelerator Stewardship

Agency: SC

01/24/2004/03/20

HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)

Agency: NIH

Institutions: NCCIHNIANIAMSNICHDNIDCRNINDSNINRNIMHDNCATSNCIOBSSR

01/23/2003/30/20

HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

01/23/2004/15/20

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNIANCI

01/23/2004/22/20

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNIANCI

01/23/2004/22/20

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNEINIMHNINDSNCI

01/23/2005/26/22

HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Agency: NIH

Institutions: NINDSNIAAANIAMSNICHDNIDCRNIDANINRNIMHDNCCIHNCIOBSSR

01/21/2003/24/20

Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Biomedical Data Repository (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

HIGH-ENERGY-DENSITY LABORATORY PLASMA SCIENCE

Agency: SC

01/16/2003/16/20

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/16/2011/17/20

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/16/2011/17/20

Public Health and Health Systems Partnerships to Increase Colorectal Cancer Screening in Clinical Settings

Agency: NCCDPHP

01/14/2003/17/20

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

American Indian Air Quality Training Program

Agency: EPA

01/13/2003/13/20

Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

01/10/2003/19/20

Innovative, Comprehensive, Cost-effective and Locally Sustainable Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control in the Republic of Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

01/09/2003/09/20

Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

01/08/2003/11/20

Supporting the Provision of Quality Cervical Cancer Screening and Pre-Cancer Treatment Services for Women Living with HIV in Botswana under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

01/07/2003/09/20

Support Government of the Kingdom of Eswatini (GKoE) to Provide Comprehensive, Quality Assured Care, Treatment and Prevention HIV/TB Services to Achieve and Sustain Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR)

Agency: CGH

01/07/2003/11/20

Health Promotion and Disease Prevention Research Centers: 2020 Special Interest Project Competitive Supplements (SIPS)

Agency: HHSCDCERA

12/23/1902/25/20

Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21- Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIMHDNIMHSGMRONCIODP

12/23/1903/13/20

DoD Breast Cancer, Era of Hope Scholar Award

Agency: AMRAA

12/23/1903/26/20

DoD Breast Cancer, Breakthrough Award Levels 1 and 2

Agency: AMRAA

12/23/1903/26/20

DoD Breast Cancer, Innovator Award

Agency: AMRAA

12/23/1906/24/20

DoD Breast Cancer, Breakthrough Award Level 3

Agency: AMRAA

12/23/1906/24/20

DoD Breast Cancer, Breakthrough Award Level 4

Agency: AMRAA

12/23/1906/24/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/10/1910/28/22

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

12/09/1909/07/22

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Co-infection and Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

11/22/1901/07/23

Atmospheric System Research (ASR)

Agency: SC

11/20/1903/10/20

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/19/1902/26/20

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/19/1902/26/20

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

11/12/1905/11/21

Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/12/1901/07/23

NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1901/07/23

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/04/1909/25/21

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: FICNIAMSNIDDKNIMHNCI

10/18/1912/03/20

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/18/1901/07/23

Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCI

10/18/1911/07/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/02/1901/07/23

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

10/02/1901/07/23

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: OPPNETNEINIANIAAANIAMSNICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR

09/18/1903/17/21

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: OPPNETNEINIANIAAANICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR

09/18/1903/17/21

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: FICNIBIBNICHDNIDCDNIMHNINDSNCIOBSSRORWH

09/13/1912/03/20

Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/13/1907/31/20

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNHLBINIDCRNCI

09/12/1901/07/23

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANIAAA

09/09/1909/07/21

Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)

Agency: NIH

Institutions: NHLBINCINIANIAID

09/09/1901/14/22

Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/06/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/05/1905/07/21

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/03/1901/10/22

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/03/1901/10/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1907/16/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/29/1903/11/22

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/28/1907/20/22

Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

08/16/1907/16/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

08/16/1909/07/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNCATS

08/05/1904/05/22

Human Exploration Research Opportunities (HERO)

Agency: JSC

07/31/1909/04/20

Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

07/30/1907/30/20

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/30/1902/11/22

Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/26/1907/30/20

Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINHLBINIAAANIDANIEHSCTP

07/08/1903/08/21

Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

06/28/1901/14/22

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1909/07/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Interaction of Ionizing Radiation with Matter University Research Alliance (IIRM-URA)

Agency: DTRA

05/30/1909/30/20

Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/22/1911/15/21

Postdoctoral Research Associate Training (PRAT) Program (Fi2)

Agency: NIH

Institutions: NIGMS

05/21/1910/04/21

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)

Agency: NIH

Institutions: FICNCINIDANIMH

05/14/1908/20/21

Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/13/1911/15/20

Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/13/1911/15/20

Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/08/1910/08/21

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH

05/08/1905/07/22

PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP

05/07/1904/06/20

PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH

05/07/1904/06/20

PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP

05/07/1904/06/20

PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH

05/07/1904/06/20

Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/01/1912/10/21

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIEHS

04/11/1911/08/21

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIEHS

04/11/1911/08/21

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/08/1906/17/21

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/13/1910/18/20

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDORIP

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINDSNLMORIP

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Agency: NIH

Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHD

02/22/1901/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHDNINDSNLMORIP

02/22/1901/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

Agency: NIH

Institutions: NCINHLBINIANIAAANIAMSNIDCRNIEHS

02/21/1901/07/22

Biology of Bladder Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Biology of Bladder Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/24/1908/03/20

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANIMHDNIMHNCINCCIHORWH

01/09/1909/07/21

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH

01/09/1909/07/21

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Agency: NIH

Institutions: NIBIBNCINIANIAAANINDS

01/08/1905/07/21

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIAMS

01/08/1901/07/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

01/08/1901/07/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

Agency: NIH

Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR

12/21/1801/07/22

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

Agency: NIH

Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH

12/21/1801/07/21

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNCCIHNIEHS

12/20/1801/07/22

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIH

12/20/1801/07/22

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIH

12/20/1801/07/22

NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIH

12/20/1801/07/22

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AID Relief) Funded Countries

Agency: SUP

12/13/1809/30/20

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/12/1807/30/20

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

12/11/1811/04/20

HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH

12/10/1802/22/21

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH

12/10/1802/22/21

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINEINICHDNIDCRNIDDKNIDANINDSNCCIHNCATS

12/10/1802/22/21

HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH

12/10/1802/22/21

Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCIOBSSR

11/28/1803/04/21

Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs

11/05/1801/07/22

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

11/02/1811/04/20

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIHNCATSNHLBIORIPNICHD

10/17/1802/02/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1804/15/21

Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1812/11/20

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/28/1807/11/21

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries

Agency: SUP

09/28/1809/30/20

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD

09/21/1801/07/22

Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINHLBINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIHOBSSRORWH

09/19/1803/12/20

Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/12/1805/07/20

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINCCIHNIAAANICHD

09/10/1809/07/21

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/07/1808/11/21

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1811/13/20

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP

08/22/1809/07/21

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHODS

08/14/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NINDSNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANINRNLMNCATSNCCIH

08/02/1803/12/20

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIAMSNIDAODS

07/25/1809/07/21

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIMHD

07/25/1809/07/21

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/24/1803/08/21

Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNCCIH

07/17/1809/07/21

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNINR

07/17/1809/07/21

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINICHDODPOBSSR

07/12/1809/10/21

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/25/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/25/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/15/21

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/15/21

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1806/14/21

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1809/10/20

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS

06/20/1809/04/21

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNCINEI

06/14/1806/03/21

Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINEINHLBINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIEHSFICNCCIHORIP

06/05/1804/15/20

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINIDDKNIEHSNCCIH

06/05/1804/15/20

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIBIBNCI

05/16/1809/07/21

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/30/1801/11/21

Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIAIDNCINIMH

04/20/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/29/1811/19/20

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD

03/28/1805/07/21

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH

03/28/1805/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINICHDODS

03/27/1805/07/21

SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIAAANIDCRNIDANINR

03/06/1804/05/21

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/21/1806/15/20

U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/21/1806/15/20

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP

02/09/1801/07/21

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/26/1801/25/21

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )

Agency: NIH

Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP

01/25/1809/07/21

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDCRNIBIB

12/21/1701/07/21

International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed

Agency: NIH

Institutions: FICNCI

12/21/1703/06/20

International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required

Agency: NIH

Institutions: FICNCI

12/21/1703/06/20

Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)

Agency: NIH

Institutions: NIBIBNCINCCIH

12/15/1709/07/20

Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANINRNIMHDNCI

12/15/1705/07/20

Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCCIHNINRNIMHDNCINHLBI

12/15/1705/07/20

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

Cancer Research Education Grants Program - Curriculum or Methods Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Research Experiences (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Courses for Skills Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/30/1711/13/20

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Agency: NIH

Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA

11/21/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNIEHSODP

11/15/1705/07/20

Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNIANIDDKNIDANIDCRNINDSNCCIHNIMHDNCI

11/07/1705/07/21

Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCININRNIANIDANIDCRNINDSNCCIHNIMHD

11/07/1705/07/21

NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCCIH

11/02/1706/29/20

Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCI

11/01/1705/07/20

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/30/1705/07/20

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH

10/17/1701/07/21

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)

Agency: NIH

Institutions: NCINIDCR

10/12/1701/07/21

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDANCCIH

10/10/1701/07/21

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/03/1701/07/21

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/29/1701/07/21

Research to Improve Native American Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR

09/29/1705/14/20

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR

09/29/1705/14/20

Stimulating Access to Research in Residency (StARR) (R38)

Agency: NIH

Institutions: NHLBINCINIAIDNIA

08/23/1705/12/20

Biology of Lung, and Head and Neck Preneoplasias (R21)

Agency: NIH

Institutions: NCI

08/16/1701/07/21

Biology of Lung, and Head and Neck Preneoplasias (R01)

Agency: NIH

Institutions: NCI

08/15/1701/07/21

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

Agency: NIH

Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD

08/01/1709/07/20

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

Agency: NIH

Institutions: NCINIAIDNIDCDNIDANIMH

07/27/1709/07/20

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21)

Agency: NIH

Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R01)

Agency: NIH

Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R21)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R01)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)

Agency: NIH

Institutions: NCI

04/04/1705/07/20

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)

Agency: NIH

Institutions: NCI

04/03/1705/07/20

Innovative Research in Cancer Nanotechnology (IRCN) (R01)

Agency: NIH

Institutions: NCI

03/30/1705/21/20

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)

Agency: NIH

Institutions: NCINHGRINIDCR

03/30/1705/07/20

Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)

Agency: NIH

Institutions: NCINHGRINIDCR

03/30/1705/07/20

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)

Agency: NIH

Institutions: NCI

03/29/1705/07/20

Mechanisms of Alcohol-associated Cancers (R21)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Mechanisms of Alcohol-associated Cancers (R01)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Thermal Transport Processes

Agency: NSF

02/22/1708/17/20

Biophotonics

Agency: NSF

02/22/1708/17/20

HIV-1 infection of the Central Nervous System (R01)

Agency: NIH

Institutions: NIMHNIAAANIANIAIDNIDANINDS

01/05/1705/07/20

Fertility Status as a Marker for Overall Health (R01)

Agency: NIH

Institutions: NICHDNIEHSODP

12/19/1605/07/20

Fundamental Research to Counter Weapons of Mass Destruction

Agency: DTRA

03/20/1509/30/24
  TOP